Tumors of the lower gastrointestinal tract;Tumoren des unteren Gastrointestinaltrakts Indikation und Ausmaß der Lymphknotendissektion

Chirurg

Volumn 81, Issue 2, 2010, Pages 117-126

  Merkel, S ^a   Weber, K ^a   Perrakis, A ^a   Gohl J ^a   Hohenberger, W ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Indication; Lower gastrointestinal tract; Lymph node dissection; Prognosis

Indexed keywords

ARTERY; ARTICLE; CANCER STAGING; COLORECTAL TUMOR; HUMAN; INTESTINE TUMOR; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORTALITY; NEUROENDOCRINE TUMOR; PATHOLOGY; PROGNOSIS; SMALL INTESTINE; SURVIVAL RATE; TUMOR EMBOLISM; TUMOR RECURRENCE; VASCULARIZATION; VEIN;

ARTERIES; COLORECTAL NEOPLASMS; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; NEUROENDOCRINE TUMORS; PROGNOSIS; SURVIVAL RATE; VEINS;

EID: 77950381215     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-009-1814-9     Document Type: Article

References (63)

1. Abrahams NA, Halverson A, FazioVW et al (2002) Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 45:1496-1502
2. Andtbacka RH, Ng CS, Scaife CL et al (2007) Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 14:14-24
3. Belli F, Gallino GF, LoVullo S et al (2009) Melanoma of the anorectal region: the experience of the National Cancer Institute of Milano. Eur J Surg Oncol 35:757-762
4. Bundesverband Deutscher Pathologen e.V. und Deutsche Gesellschaft für Pathologie e.V. (2005) Version 1.0 Empfehlungen zur pathologisch-anatomischen Diagnostik des kolorektalen Karzinoms. Erhältlich über: http://www.bv-pathologie.de/mitgliederbereich/download.php?f=leitlinie_kolo_karzinom.pdf
5. Bittner R, Burghardt J, Gross E et al (2007) Qualitätsindikatoren der Diagnostik undTherapie des Rektumkarzinoms. Zentralbl Chir 132:85-94
6. Blay JY, Bonvalot S, Casali P et al (2005) Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 16:566-578
7. Cahill RA (2007)What's wrong with sentinel node mapping in colon cancer?World J Gastroenterol 13:6291-6294
8. Chang GJ, Rodriguez-Bigas MA, Skibber JM et al (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433-441
9. Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244:602-610
10. Dabaja BS, Suki D, Pro B et al (2004) Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101:518-526
11. Damin DC, Rosito MA, Schwartsmann G (2006) Sentinel lymph node in carcinoma of the anal canal: a review. Eur J Surg Oncol 32:247-252
12. Daum S, Ullrich R, HeiseW (2003) Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J Clin Oncol 21:2740-2746
13. Dillman RO, Aaron K, Heinemann FS et al (2009) Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer 115:1840-1848
14. Doekhie FS, MeskerWE, Kuppen PJ et al (2009) Detailed examination of lymph nodes improves prognostication in colorectal cancer. Int J Cancer [Epub ahead of print]
15. Ducreux M, Boutron MC, Piard F et al (1998) A 15-year series of gastrointestinal non-Hodgkin's lymphomas: a population-based study. Br J Cancer 77:511-514
16. Earle CC,Weiser MR,TerVeer A et al (2009) Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer. J Surg Oncol [Epub ahead of print]
17. FischbachW (2004) Gastrointestinale Lymphome. Z Gastroenterol 42:1067-1072
18. Fornaro R, Picori E, Stabilini C et al (2006) Carcinoid tumors of the appendix: when right colectomy? G Chir 27:233-239
19. Gervaz P, Huber O, Morel P (2009) Surgical management of gastrointestinal stromal tumours. Br J Surg 96:567-578
20. Giedl J (1986) Lymphknotenmetastasen kolorektaler Karzinome. Häufigkeit undTopographie. Fortschr Med 104:167-170
21. Hermanek P (2000) Lymphknoten und maligneTumorkrankheit. Zentralbl Chir 125:790-795
22. Hida J,Yasutomi M, Fujimoto K et al (1997) Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. J Am Coll Surg 184:475-480
23. Hölzel D, Engel J, Löhrs U (2008) Sind elektive Lymphknotendissektionen in der Karzinomchirurgie noch zeitgemäß? Zentralbl Chir 133:582-589
24. Hölzel D, Eckel R, Engel J (2009) Metastasierung beim kolorektalen Karzinom. Häufigkeiten, Prognose und Folgerungen. Chirurg 80:331-340
25. Hohenberger P,Wardelmann E (2006) Gastrointestinale Stromatumoren.Was der Chirurg wissen muss. Chirurg 77:33-40
26. HohenbergerW, Merkel S,Weber K (2007) Lymphadenektomie beiTumoren des unteren Gastrointestinaltrakts. Chirurg 78:217-225
27. HohenbergerW (2007) Offene Rektumchirurgie. Chirurg 78:739-747
28. HohenbergerW,Weber K, Matzel K et al (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome. Colorectal Dis 11:354-365
29. Howe JR, Karnell LH, Menck HR et al (1999)The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer 86:2693-2706
30. Jinnai D (1983) General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese Research Society for Cancer of the Colon and Rectum. Jpn J Surg 13:557-573
31. KelderW, Inberg B, Schaapveld M et al (2009) Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands. Dis Colon Rectum 52:260-267
32. Kikuchi R,Takano M,Takagi K et al (1995) Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 38:1286-1295
33. KimYW, Kim NK, Min BS et al (2009)The influence of the number of retrieved lymph nodes on sta- ging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg 249:965-972
34. KimYW, Kim NK, Min BS et al (2009)The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. J Surg Oncol 100:1-7
35. KimYS, Kim JH,Yoon SM et al (2009) Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J Radiat Oncol Biol Phys 74:796-802
36. Köckerling F, Reymond MA, Altendorf-Hofmann A et al (1998) Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 16:324-329
37. Landry CS, Brock G, Scoggins CR et al (2008) Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients. J Am Coll Surg 207:874-881
38. LeVoyerTE, Sigurdson ER, Hanlon AL et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912-2919
39. Lopez-Kostner F, Lavery IC, Hool GR et al (1998)Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery 124:612-618
40. Matzel KE, Merkel S, HohenbergerW (2003) LokaleTherapieprinzipien beim Rektumkarzinom. Chirurg 74:897-904
41. Merkel S, Klossek D, Göhl J et al (2009) Quality management in rectal carcinoma: what is feasible? Int J Colorectal Dis 24:931-942
42. Modlin IM, Kidd M, Latich I et al (2005) Current status of gastrointestinal carcinoids. Gastroenterology 128:1717-1751
43. Nagtegaal ID,Velde CJH van de,Worp E van der et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729-1734
44. Nascimbeni R, Burgart LJ, Nivatvongs S et al (2002) Risk of lymph node metastasis inT1 carcinoma of the colon and rectum. Dis Colon Rectum 45:200-206
45. Nicholl MB,Wright BE, ConwayWC et al (2009) Does specialized surgical training increase lymph node yield in colon cancer? Am Surg 75:887-891
46. Nilsson PJ, Svensson G, Goldman S et al (2005) Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat On-col Biol Phys 61:92-102
47. Olsha O, Mintz A, Gimon Z et al (2005) Anal melanoma in the era of sentinel lymph node mapping: a diagnostic and therapeutic challenge.Tech Coloproctol 9:60-62
48. Parfitt JR, Driman DK (2007)The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol 60:849-855
49. Rosenberg R, Friederichs J, SchusterT et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg 248:968-978
50. Scherübl H, Klöppel G (2009) Neuroendokrine Neoplasien des Rektums auf demVormarsch ein Update. Z Gastroenterol 47:365-371
51. Sobin LH,Wittekind CH (eds) UICC (2002)TNM classification of malignant tumours, 6th edn. John Wiley & Sons, Inc., NewYork
52. Sobin LH, Gospodarowicz M, Wittekind CH (eds) UICC (2009)TNM classification of malignant tumours, 7th edn.Wiley-Blackwell, NewYork
53. Sutton R, Doran HE,Williams EM et al (2003) Surgery for midgut carcinoid. Endocr Relat Cancer 10:469-481
54. Swanson RS, Compton CC, Stewart AK et al (2003) The prognosis ofT3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65-71
55. TranT, Davila JA, El-Serag HB (2005)The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 100:162-168
56. Vaccaro CA, ImV, Rossi GL et al (2009) Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum 52:1244-1250
57. Vather R, SammourT, Zargar-Shoshtari K et al (2009) Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer. Int J Colorectal Dis 24:283-288
58. Veyrières M, Baillet P, Hay JM et al (1997) Factors influencing long-term survival in 100 cases of small intestine primary adenocarcinoma. Am J Surg 173:237-239
59. West NP, Morris EJ, Rotimi O et al (2008) Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 9:857-865
60. West NP, HohenbergerW,Weber K et al (2009) Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol in press
61. Westdeutsches Darm-Centrum GmbH, Benchmarking DarmzentrenWDC, Jahresbericht (2008) Erhältlich über: http://www.darm-centrum.de/doc/controls/document/docrender.aspx?ID=107
62. Wittekind CH, Greene FL, Henson DE et al (eds) UICC (2003)TNM Supplement. A commentary on uniform use. 3rd edn.Wiley-Liss, NewYork
63. WuTJ,Yeh CN, ChaoTC et al (2006) Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis.World J Surg 30:391-399